Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein

Area of Science:

• Molecular Biology
• Oncology
• Hepatocellular Carcinoma Research

Background:

• CCAAT/enhancer-binding protein alpha (C/EBP alpha) is a transcription factor involved in cell differentiation.
• Hepatocellular carcinoma (HCC) is a major global health concern characterized by uncontrolled cell proliferation.
• Understanding factors that regulate hepatoma cell growth is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To investigate the effect of C/EBP alpha expression on the proliferation and tumorigenicity of human hepatocellular carcinoma cell lines.
• To determine if C/EBP alpha can induce a differentiated or quiescent state in hepatoma cells, thereby suppressing their malignant potential.

Main Methods:

• Construction of a plasmid for inducible C/EBP alpha expression using the metallothionein promoter.
• Transfection of human HCC cell lines (Hep3B and HepG2) with the constructed plasmid.
• In vitro growth assays, soft agar clonogenic assays, and in vivo tumorigenicity studies in immunodeficient mice.

Main Results:

• C/EBP alpha expression induced reversible growth arrest in HCC cells cultured in vitro.
• Expression of C/EBP alpha significantly reduced colony formation in soft agar assays.
• HCC cells expressing C/EBP alpha exhibited suppressed tumorigenicity in vivo, with delayed tumor appearance in SCID mice.

Conclusions:

• Endogenous C/EBP alpha expression can impair the proliferative activity of hepatoma cell lines.
• C/EBP alpha acts as a suppressor of tumorigenicity in hepatocellular carcinoma.
• Re-expression of differentiation-associated genes like C/EBP alpha may offer a potential therapeutic strategy for HCC.